ValoTec stems from Ecole Normale Supérieure de Paris-Salcay (SATIE laboratory) one of the best research centers in France, and accompanies it’s clients since 2005 in their R&D projects and production projects ValoTec is specialized in the following domains : Active innovative devices (all industries) Class IIa IIb and III medical devices (MedTech) Implantable devices Patient treatment devices Diagnostic devices In 2019, ValoTec launched MELLIsim , it’s subsidiary dedicated to a research program on diabetes In 2020, ValoTec acquired Futurs Health Products, a company specialized in innovation management, clinical, regulatory and medico-economic strategy for medical devices ValoTec is a Member of Medicen, Systematic and Biowin and is labeled as « Société de Recherche Sous Contrat » (SRC) by BPI France (French bank of Investment) Since 2012, ValoTec is certified ISO 9001 (technical devices) and ISO 13485 (medical devices) for consultancy, development, manufacturing/distribution ValoTec is also approved for CIR & CII tax credits for research in France.